Leucine-Rich Repeat Kinase 2 Colocalizes with α-Synuclein in Parkinson’s Disease, but Not Tau-Containing Deposits in Tauopathies

Publisher： Karger

E-ISSN： 1660-2862|5|3-4|222-224

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.5, Iss.3-4, 2008-03, pp. : 222-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation

By  

Neurodegenerative Diseases, Vol. 7, Iss. 1-3, 2010-03 ,pp. : 175-179

Karger

Access to resources Recommend Favorite

The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease

By Yasuda Toru  

Apoptosis, Vol. 15, Iss. 11, 2010-11 ,pp. : 1312-1321

Springer Publishing Company

Access to resources Recommend Favorite

The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia

By  

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-09 ,pp. : 154-156

Karger

Access to resources Recommend Favorite

Delay Discounting of Reward and Caudate Nucleus Volume in Individuals with α-Synuclein Gene Duplication before and after the Development of Parkinson’s Disease

By  

Neurodegenerative Diseases, Vol. 11, Iss. 2, 2012-10 ,pp. : 72-78

Karger

Access to resources Recommend Favorite

α-Synuclein in Parkinson's Disease: Pathogenic Function and Translation into Animal Models

By  

Neurodegenerative Diseases, Vol. 14, Iss. 1, 2013-09 ,pp. : 1-17

Karger

Access to resources Recommend Favorite